Overview
Humdum Durrani is a Hematologist in Jonesboro, Arkansas. Dr. Durrani is highly rated in 67 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, and Bone Marrow Aspiration.
His clinical research consists of participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE PART D
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
225 E Washington Ave, Jonesboro, AR 72401
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
St. Jude Children's Research Hospital
Amar Gajjar is a Hematologist and an Oncologist in Memphis, Tennessee. Dr. Gajjar is highly rated in 13 conditions, according to our data. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Posterior Fossa Decompression.
St. Jude Children's Research Hospital
Marcin Wlodarski is a Hematologist and an Oncologist in Memphis, Tennessee. Dr. Wlodarski is highly rated in 15 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Dyskeratosis Congenita, Bone Marrow Transplant, and Splenectomy.
St. Jude Children's Research Hospital
Jeremie Estepp is a Hematologist and an Oncologist in Memphis, Tennessee. Dr. Estepp is highly rated in 11 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Splenectomy, and Adenoidectomy.
Frequently Asked Questions about Dr. Humdum Durrani
How do I make an appointment with Dr. Humdum Durrani?
You can book an appointment with Dr. Humdum Durrani by calling their office at 870-207-8177. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Humdum Durrani a top-rated expert for Pleuropulmonary Blastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Humdum Durrani is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Humdum Durrani specialize in?
While Dr. Humdum Durrani is a Hematology, they have specific expertise in Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Humdum Durrani accept my insurance?
Dr. Humdum Durrani accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 870-207-8177 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Durrani isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AngiosarcomaDr. Durrani isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Durrani isDistinguished. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Durrani isDistinguished. Learn about EGFR Positive Lung Cancer.
- Gastroesophageal Junction CancerDr. Durrani isDistinguished. Learn about Gastroesophageal Junction Cancer.
- Inflammatory Breast CancerDr. Durrani isDistinguished. Learn about Inflammatory Breast Cancer.
- Advanced
- Acute Mountain SicknessDr. Durrani isAdvanced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Durrani isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Durrani isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Durrani isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Durrani isAdvanced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Durrani isAdvanced. Learn about Antiphospholipid Syndrome.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Durrani isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Durrani isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Durrani isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Durrani isExperienced. Learn about Acute Promyelocytic Leukemia.